Ann: Opthea to Present at Ophthalmology Innovation Summit in US-OPT.AX, page-8

Thanks Sol for keeping us in the loop. In the absence of any other obvious reason one would have to surmise this report is the instigator for the share price spike over the last couple of days. I have been following and investing in Australian biotech stocks for a good few years now, going back to the days when Bioshares first came on the scene and was posted out as a quarterly magazine. Thankfully I've still got the shirt on my back (the same one unfortunately albeit I've lost a few buttons). Along the way I have read many a report from the likes of Stuart Roberts on promising biotech minnows with blue sky share price estimations. With very few exceptions these for various reasons have failed to materialise. I'd be mightily impressed if OPT gets anywhere near $5.80, anywhere north of $2.00 I'd happily take.

My considered approach to investing in developing biotech companies is (for those old enough to remember) now firmly based on the lyrics in Kenny Rogers song the Gambler.

Every gambler knows
That the secret to survivin'
Is knowin' what to throw away
And knowin' what to keep
'Cause every hand's a winner
And every hand's a loser

You've got to know when to hold 'em
Know when to fold 'em
Know when to walk away
And know when to run

Cheers Yehudi